BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31605115)

  • 1. Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas.
    Lightner AL; Dozois EJ; Dietz AB; Fletcher JG; Friton J; Butler G; Faubion WA
    Inflamm Bowel Dis; 2020 Apr; 26(5):670-677. PubMed ID: 31605115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Results of a Phase I Trial Using an Adipose-Derived Mesenchymal Stem Cell-Coated Fistula Plug for the Treatment of Transsphincteric Cryptoglandular Fistulas.
    Dozois EJ; Lightner AL; Mathis KL; Chua HK; Kelley SR; Fletcher JG; Dietz AB; Friton JJ; Butler GW; Faubion WA
    Dis Colon Rectum; 2019 May; 62(5):615-622. PubMed ID: 30664554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase IB/IIA study of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn's disease.
    Lightner AL; Reese JS; Ream J; Nachand D; Dadgar N; Adams A; VanDenBossche A; Pineiro AO; Hull T
    Surgery; 2024 Feb; 175(2):242-249. PubMed ID: 37661485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
    Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
    Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.
    Lightner AL; Pineiro AO; Reese J; Ream J; Nachand D; Adams AC; Dadgar N; Hull T
    Surgery; 2024 Apr; 175(4):984-990. PubMed ID: 38097485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of the button fistula plug in the treatment of Ileal pouch-vaginal and Crohn's-related rectovaginal fistulas.
    Gajsek U; McArthur DR; Sagar PM
    Dis Colon Rectum; 2011 Aug; 54(8):999-1002. PubMed ID: 21730789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy.
    García-Olmo D; García-Arranz M; García LG; Cuellar ES; Blanco IF; Prianes LA; Montes JA; Pinto FL; Marcos DH; García-Sancho L
    Int J Colorectal Dis; 2003 Sep; 18(5):451-4. PubMed ID: 12756590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
    Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA
    Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.
    Dietz AB; Dozois EJ; Fletcher JG; Butler GW; Radel D; Lightner AL; Dave M; Friton J; Nair A; Camilleri ET; Dudakovic A; van Wijnen AJ; Faubion WA
    Gastroenterology; 2017 Jul; 153(1):59-62.e2. PubMed ID: 28400193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation.
    García-Olmo D; García-Arranz M; Herreros D; Pascual I; Peiro C; Rodríguez-Montes JA
    Dis Colon Rectum; 2005 Jul; 48(7):1416-23. PubMed ID: 15933795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Dige A; Hougaard HT; Agnholt J; Pedersen BG; Tencerova M; Kassem M; Krogh K; Lundby L
    Gastroenterology; 2019 Jun; 156(8):2208-2216.e1. PubMed ID: 30772343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Laureti S; Gionchetti P; Cappelli A; Vittori L; Contedini F; Rizzello F; Golfieri R; Campieri M; Poggioli G
    Inflamm Bowel Dis; 2020 Jan; 26(2):321-330. PubMed ID: 31220252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Li Z
    Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch.
    Lightner AL; Reese J; Ream J; Nachand D; Jia X; Pineiro AO; Dadgar N; Steele S; Hull T
    J Crohns Colitis; 2023 Apr; 17(4):480-488. PubMed ID: 36322714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical case report of local microinjection of autologous fat and adipose-derived stromal vascular fraction for perianal fistula in Crohn's disease.
    Philandrianos C; Serrero M; Grimaud F; Magalon J; Visée C; Velier M; Francois P; Orsoni P; Magalon G; Grimaud JC; Desjeux A; Véran J; Sabatier F
    Stem Cell Res Ther; 2018 Jan; 9(1):4. PubMed ID: 29321063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous fibrin glue in the treatment of rectovaginal and complex fistulas.
    Abel ME; Chiu YS; Russell TR; Volpe PA
    Dis Colon Rectum; 1993 May; 36(5):447-9. PubMed ID: 8482163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results on efficacy in closure of transsphincteric and rectovaginal fistulas associated with Crohn's disease using new biomaterials.
    Schwandner O; Fuerst A
    Surg Innov; 2009 Jun; 16(2):162-8. PubMed ID: 19502244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of function and predictors of failure in women undergoing repair of Crohn's related rectovaginal fistula.
    El-Gazzaz G; Hull T; Mignanelli E; Hammel J; Gurland B; Zutshi M
    J Gastrointest Surg; 2010 May; 14(5):824-9. PubMed ID: 20232172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
    Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.